🔴 Neumora Therapeutics is trading 10.3% down — no clear company-specific catalyst identified

Neumora Therapeutics is trading 10.3% lower at $0.49; no clear company-specific catalyst has been identified for October 2, 2026.

• Investor relations lists August 14, 2026, as the latest press release, with no newer announcement shown.
• The broader market is higher on weaker-than-expected September jobs data; the decline does not appear to reflect the prevailing market direction.
• Recent consecutive declines provide context but do not identify a catalyst.